Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
SMARTSCORE: 2.6/5
Yunkang Group (2325 HK)
Watchlist
27
Analysis
Health Care
•
China
Yunkang Group Limited operates as a medical operation service provider. The Company provides diagnostic outsourcing services, diagnostic testing, and other services. Yunkang Group provides its services throughout China.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
JD.com Inc (ADR)
•
21 May 2022 23:47
ECM Weekly (22nd May 22) - JD, LIC, Delhivery, Leapmotor, Vista, Paradeep, Woori, Hyundai Heavy, NIO
Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
Sumeet Singh
Follow
591 Views
Share
bearish
•
Yunkang Group
•
17 May 2022 03:12
Yunkang Group IPO Trading - Subdued Subscription Rates Combined with Uncertain Future Profitability
Yunkang Group (2325 HK) raised around US$139m in its Hong Kong IPO. On its bookbuild, subscription rates were lackluster and market sentiment...
Clarence Chu
Follow
396 Views
Share
bullish
•
Life Insurance of India
•
15 May 2022 00:08
ECM Weekly (15th May 22) - LIC, ThaiBev, Delhivery, One Store, Yunkang, VistaREIT, Ngern Tid Lor
Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
Sumeet Singh
Follow
550 Views
Share
bullish
•
Life Insurance of India
•
09 May 2022 00:22
ECM Weekly (9th May 22) - LIC, Campus, Rainbow, Delhivery, Shieldus, Yunkang, PAG, Keep, Air NZ
Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
Sumeet Singh
Follow
418 Views
Share
bearish
•
Yunkang Group
•
08 May 2022 01:52
Yunkang Group IPO - Futile to Try and Gauge Its Post-COVID Performance
Yunkang Group (2325 HK) is looking to raise US$139m in its Hong Kong IPO. Were China to lift its lockdown status, inline with global trends, the...
Clarence Chu
Follow
2k Views
Share
First
Previous
1
2
3
4
5
6
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.5
x